These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1154333)

  • 1. Neutralization of heparin by cellular blood elements.
    Zuckerman L; Ramstack JM; Vagher JP; Caprini JA; Mockros LF
    Thromb Res; 1975 Jul; 7(1):149-59. PubMed ID: 1154333
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of aspirin on the blood coagulation system of rheumatic children].
    Briazgunov IP
    Vopr Okhr Materin Det; 1966 Nov; 11(11):61-5. PubMed ID: 5996732
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation and some properties of the heparin-neutralizing factor (PF4) released from human blood platelets.
    Käser-Glanzmann R; Jakábová M; Lüscher EF
    Experientia; 1972 Oct; 28(10):1221-3. PubMed ID: 5087047
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemorheological studies of the effect of heparin on the course of coagulation.
    Overholser KA; Baysinger CB; Harris TR; Deveau T
    Thromb Haemost; 1976 Apr; 35(2):447-59. PubMed ID: 989642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin neutralization by recombinant platelet factor 4 and protamine.
    Levy JH; Cormack JG; Morales A
    Anesth Analg; 1995 Jul; 81(1):35-7. PubMed ID: 7598278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of low-density lipoproteins of the blood plasma during labor in heparin neutralization].
    Rółkowski R; Skrzydlewski Z; Worowski K
    Zentralbl Gynakol; 1985; 107(8):491-5. PubMed ID: 4013548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiheparin and heparin activity of blood in various stages of pregnancy].
    Kreminskaia IaM
    Pediatr Akus Ginekol; 1970; 4():33-5. PubMed ID: 5504823
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].
    Harenberg J; Giese C; Knödler A; Zimmermann R; Schettler G
    Klin Wochenschr; 1986 Nov; 64(22):1171-5. PubMed ID: 3807263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surface electrical properties of the formed elements of the blood and blood coagulation properties].
    Ermolaev IuA
    Biull Eksp Biol Med; 1975 Mar; 79(3):11-4. PubMed ID: 1125399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An optimal coagulation method to determine anti-heparin compounds in biological specimens].
    Roszkowska-Jakimiec W
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1986-1987; 31-32():143-51. PubMed ID: 3152143
    [No Abstract]   [Full Text] [Related]  

  • 11. A COMPARISON OF THE EFFECT OF PLATELETS AND ERYTHROCYTES ON THE INHIBITORY ACTION OF BLOOD COAGULATION BY POLYBRENE AND HEPARIN.
    SHANBERGE JN; FURUTA S
    Thromb Diath Haemorrh; 1964 Oct; 12():137-47. PubMed ID: 14224630
    [No Abstract]   [Full Text] [Related]  

  • 12. Assay of platelet factor 4 in plasma.
    Fuster V; Kazmier FJ; Cash JD; Bowie EJ; Owen CA
    Mayo Clin Proc; 1973 Feb; 48(2):103-6. PubMed ID: 4689655
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of acridine dyes on heparin activity and blood coagulation].
    Berge H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(4):419-25. PubMed ID: 4107578
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of heparin inactivation by thromboplastin (factor III)].
    Byshevskiĭ ASh; Mikhaleva IV; Galenko OV; Tersenov OA
    Ukr Biokhim Zh (1978); 1987; 59(4):3-8. PubMed ID: 3629728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin release is insufficient in syringes with platelets as heparin source.
    Gruber M; Spaeth R; Bechmann V
    Clin Chim Acta; 2008 Sep; 395(1-2):187. PubMed ID: 18515082
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III.
    Teien AN; Lie M
    Thromb Res; 1977 Mar; 10(3):399-410. PubMed ID: 854877
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet-derived heparin neutralizing proteins.
    Lane DA
    Adv Exp Med Biol; 1985; 192():427-38. PubMed ID: 2939696
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT).
    Bode AP; Castellani WJ; Hodges ED; Yelverton S
    Thromb Haemost; 1991 Aug; 66(2):213-7. PubMed ID: 1771614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.